Fundamentals of Quantitative Dynamic Contrast-Enhanced MR Imaging

Magnetic Resonance Imaging Clinics of North America

Volumn 17, Issue 2, 2009, Pages 277-289

  Paldino, Michael J ^a   Barboriak, Daniel P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dynamic contrast enhanced MR imaging; Oncology; Perfusion; Physics

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIDOL;

CONTRAST ENHANCEMENT; DATA ANALYSIS; DRUG DISTRIBUTION; DRUG EFFECT; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; REVIEW;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MATHEMATICS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 65249105448     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2009.01.007     Document Type: Review

References (79)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 3 (1992) 65-71
2. Knopp M.V., Giesel F.L., Marcos H., et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 12 (2001) 301-308
3. Dadiani M., Furman-Haran E., and Degani H. The application of NMR in tumor angiogenesis research. Progress in Nuclear Magnetic Resonance Spectroscopy 49 (2006) 27-44
4. Jubb A.M., Oates A.J., Holden S., et al. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer 6 (2006) 626-635
5. Mukhopadhyay D., Tsiokas L., Zhou X.M., et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375 (1995) 577-581
6. Padhani A.R. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16 (2002) 407-422
7. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
8. Gaustad J.V., Brurberg K.G., Simonsen T.G., et al. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 10 (2008) 354-362
9. Delorme S., and Knopp M.V. Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiol 8 (1998) 517-527
10. Dvorak A.M., Kohn S., Morgan E.S., et al. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59 (1996) 100-115
11. Knopp M.V., Weiss E., Sinn H.P., et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10 (1999) 260-266
12. Kaur B., Tan C., Brat D.J., et al. Genetic and hypoxic regulation of angiogenesis in gliomas. J Neurooncol 70 (2004) 229-243
13. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
14. O'Connor J.P., Jackson A., Parker G.J., et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96 (2007) 189-195
15. Cheng H.L. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 28 (2008) 736-743
16. Brix G., Semmler W., Port R., et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15 (1991) 621-628
17. Evelhoch J.L. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10 (1999) 254-259
18. Ashton E, Durkin E, Kwok E, et al. Conversion from signal intensity to Gd concentration may be unnecessary for perfusion assessment of tumors using DCE-MRI. Presented at the Proceedings of the International Society for Magnetic Resonance in Medicine. Berlin, 2007.
19. Evelhoch J.L. Consensus recommendations for acquisition of dynamic contrasted-enhanced MRI data in oncology. In: Jackson A., Buckley D.L., and Parker G.J. (Eds). Dynamic contrast-enhanced magnetic resonance imaging in oncology. 1st edition vol 1 (2005), Springer, Berlin/Heidelberg (NY) 109-113
20. Leach M.O., Brindle K.M., Evelhoch J.L., et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92 (2005) 1599-1610
21. Wang H.Z., Riederer S.J., and Lee J.N. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 5 (1987) 399-416
22. Deoni S.C., Rutt B.K., and Peters T.M. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 49 (2003) 515-526
23. Jahng G.H., Stables L., Ebel A., et al. Sensitive and fast T1 mapping based on two inversion recovery images and a reference image. Med Phys 32 (2005) 1524-1528
24. Ogg R.J., and Kingsley P.B. Optimized precision of inversion-recovery T1 measurements for constrained scan time. Magn Reson Med 51 (2004) 625-630
25. Karlsson M., and Nordell B. Analysis of the Look-Locker T(1) mapping sequence in dynamic contrast uptake studies: simulation and in vivo validation. Magn Reson Imaging 18 (2000) 947-954
26. Freeman A.J., Gowland P.A., and Mansfield P. Optimization of the ultrafast Look-Locker echo-planar imaging T1 mapping sequence. Magn Reson Imaging 16 (1998) 765-772
27. Buckley D.L., and Parker G.J. Measuring contrast agent concentration in T1-weighted dynamic contrast enhanced MRI. In: Jackson A., Buckley D.L., and Parker G.J. (Eds). Dynamic contrast-enhanced magnetic resonance imaging in oncology. 1st edition vol 1 (2005), Springer, Berlin/Heidelberg (NY) 69-79
28. Haase A. Snapshot FLASH MR imaging. Applications to T1, T2, and chemical-shift imaging. Magn Reson Med 13 (1990) 77-89
29. Cercignani M., Symms M.R., Schmierer K., et al. Three-dimensional quantitative magnetisation transfer imaging of the human brain. Neuroimage 27 (2005) 436-441
30. Heidemann R.M., Ozsarlak O., Parizel P.M., et al. A brief review of parallel magnetic resonance imaging. Eur Radiol 13 (2003) 2323-2337
31. Tsao J., Boesiger P., and Pruessmann K.P. k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 50 (2003) 1031-1042
32. Storey P, Ko JP, Nonaka D, et al. Dynamic 3D contrast-enhanced perfusion imaging of lung cancer with one-second temporal resolution. Presented at a meeting of the International Society for Magnetic Resonance in Medicine. Toronto, 2008.
33. Rijpkema M., Kaanders J.H., Joosten F.B., et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14 (2001) 457-463
34. Ramsay E., Causer P., Hill K., et al. Adaptive bilateral breast MRI using projection reconstruction time-resolved imaging of contrast kinetics. J Magn Reson Imaging 24 (2006) 617-624
35. Mistretta C.A., Wieben O., Velikina J., et al. Highly constrained backprojection for time-resolved MRI. Magn Reson Med 55 (2006) 30-40
36. O'Halloran R.L., Wen Z., Holmes J.H., et al. Iterative projection reconstruction of time-resolved images using highly-constrained back-projection (HYPR). Magn Reson Med 59 (2008) 132-139
37. Knoll F, Ebner F, Keeling S, et al. Assessment of image reconstruction methods for subsampled DCE-MRI. Presented at a meeting of the International Society for Magnetic Resonance in Medicine. Toronto, 2008.
38. Daniel B.L., Yen Y.F., Glover G.H., et al. Breast disease: dynamic spiral MR imaging. Radiology 209 (1998) 499-509
39. Parker G.J., Suckling J., Tanner S.F., et al. MRI: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. Radiographics 18 (1998) 497-506
40. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 101-1010
41. Gribbestad I.S., Nilsen G., Fjosne H.E., et al. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 4 (1994) 477-480
42. Jackson A., O'Connor J.P., Parker G.J., et al. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13 (2007) 3449-3459
43. Gribbestad I.S., Gjesdal K.I., Nilsen G., et al. An introduction to dynamic contrast-enhanced MRI in oncology. In: Jackson A., Buckley D.L., and Parker G.J. (Eds). Dynamic contrast-enhanced MRI in oncology. 1st edition vol 1 (2005), Springer, Berlin/Heidelberg (NY) 3-22
44. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
45. Tofts P.S., and Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17 (1991) 357-367
46. Brix G., Bahner M.L., Hoffmann U., et al. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology 210 (1999) 269-276
47. Donahue K.M., Weisskoff R.M., and Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 7 (1997) 102-1010
48. Parker G.J., and Buckley D.L. Tracer kinetic modelling for T1-weighted DCE-MR imaging. In: Jackson A., Parker G.J., and Buckley D.L. (Eds). Dynamic contrast-enhanced magnetic resonance imaging in oncology. 1st edition vol 1 (2005), Springer, Berlin/Heidelberg (NY) 81-92
49. St Lawrence K.S., and Lee T.Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 18 (1998) 1365-1377
50. Buckley D.L., Roberts C., Parker G.J., et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR -initial experience. Radiology 233 (2004) 709-715
51. Buckley D.L. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 47 (2002) 601-606
52. Henderson E., Rutt B.K., and Lee T.Y. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 16 (1998) 1057-1073
53. Ashton E., Raunig D., Ng C., et al. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging 28 (2008) 791-796
54. Tseng Y.C., Hsu H.L., Lee T.H., et al. Venous reflux on carotid computed tomography angiography: relationship with left-arm injection. J Comput Assist Tomogr 31 (2007) 360-364
55. You S.Y., Yoon D.Y., Choi C.S., et al. Effects of right- versus left-arm injections of contrast material on computed tomography of the head and neck. J Comput Assist Tomogr 31 (2007) 677-681
56. Lee Y.J., Chung T.S., Joo J.Y., et al. Suboptimal contrast-enhanced carotid MR angiography from the left brachiocephalic venous stasis. J Magn Reson Imaging 10 (1999) 503-509
57. Calamante F., Gadian D.G., and Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 33 (2002) 1146-1151
58. Calamante F. Bolus dispersion issues related to the quantification of perfusion MRI data. J Magn Reson Imaging 22 (2005) 718-722
59. Harrer J.U., Parker G.J., Haroon H.A., et al. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. J Magn Reson Imaging 20 (2004) 748-757
60. van Osch M.J., Vonken E.J., Viergever M.A., et al. Measuring the arterial input function with gradient echo sequences. Magn Reson Med 49 (2003) 1067-1076
61. Yang C., Karczmar G.S., Medved M., et al. Multiple reference tissue method for contrast agent arterial input function estimation. Magn Reson Med 58 (2007) 1266-1275
62. Teifke A., Behr O., Schmidt M., et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology 239 (2006) 351-360
63. Gaustad J.V., Benjaminsen I.C., Graff B.A., et al. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 21 (2005) 792-800
64. Jackson A., Kassner A., Annesley-Williams D., et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23 (2002) 7-14
65. de Lussanet Q.G., Backes W.H., Griffioen A.W., et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1309-1315
66. Li K.L., Wilmes L.J., Henry R.G., et al. Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI. J Magn Reson Imaging 22 (2005) 511-519
67. Rose C.J., Mills S., O'Connor J.P., et al. Quantifying heterogeneity in dynamic contrast-enhanced MRI parameter maps. In: Ayache N., Ourselin A., and Maeder A. (Eds). Lecture notes in computer science Vol 4792 (2007), Springer, Verlag/Berlin/Heidelberg (NY) 376-384
68. Hamstra D.A., Chenevert T.L., Moffat B.A., et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102 (2005) 16759-16764
69. Heywang-Kobrunner S.H., Haustein J., Pohl C., et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 191 (1994) 639-646
70. Sardanelli F., Iozzelli A., Fausto A., et al. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 235 (2005) 791-797
71. Roberts T.P., and Noseworthy M.D. Contrast agents for magnetic resonance. In: Jackson A., Buckley D.L., and Parker G.J. (Eds). Dynamic contrast-enhanced magnetic resonance imaging in oncology. 1st edition vol 1 (2005), Springer, Berlin/Heidelberg (NY) 23-37
72. Barrett T., Brechbiel M., Bernardo M., et al. MRI of tumor angiogenesis. J Magn Reson Imaging 26 (2007) 235-249
73. Barrett T., Kobayashi H., Brechbiel M., et al. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 60 (2006) 353-366
74. Marzola P., Degrassi A., Calderan L., et al. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res 11 (2005) 5827-5832
75. Daldrup H., Shames D.M., Wendland M., et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 171 (1998) 941-949
76. Turetschek K., Floyd E., Helbich T., et al. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J Magn Reson Imaging 14 (2001) 237-242
77. Preda A., Novikov V., Moglich M., et al. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. J Magn Reson Imaging 20 (2004) 865-873
78. Turetschek K., Roberts T.P., Floyd E., et al. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 13 (2001) 882-888
79. Law M., Young R.J., Babb J.S., et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247 (2008) 490-498